Best Autologous Chondrocyte Implantation (ACI) Hospitals in Israel

Rabin Medical Center provides Autologous Chondrocyte Implantation using contemporary cell-based cartilage repair techniques and evidence-based orthopaedic care. Founded in 1996, the JCI hospital is based in Petah Tikva, Israel, with 1300 beds and services for domestic and international patients.

During ACI, a small sample of healthy cartilage is collected, and the chondrocytes are expanded under controlled laboratory conditions. The cultured cells are subsequently placed into the cartilage defect to support tissue repair. Before treatment, specialists assess cartilage damage, joint alignment, stability, imaging findings, and the patient's overall health.

With advanced orthopaedic and cartilage-care infrastructure, Sheba Medical Center offers Autologous Chondrocyte Implantation (ACI) for eligible patients with specific cartilage injuries. Established in 1948, the JCI hospital is located in Ramat Gan, Israel, and has 1900 beds.

ACI may be considered for symptomatic, localised cartilage defects when other treatments have not provided adequate relief. The patient's own cartilage cells are harvested, multiplied in a laboratory, and later implanted into the affected area. A detailed evaluation of the cartilage lesion and surrounding joint structures is performed before treatment.

Herzliya Medical Center provides Autologous Chondrocyte Implantation using contemporary cell-based cartilage repair techniques and evidence-based orthopaedic care. Founded in 1983, the hospital is based in Herzliya, Israel, with 120 beds and services for domestic and international patients.

During ACI, a small sample of healthy cartilage is collected, and the chondrocytes are expanded under controlled laboratory conditions. The cultured cells are subsequently placed into the cartilage defect to support tissue repair. Before treatment, specialists assess cartilage damage, joint alignment, stability, imaging findings, and the patient's overall health.

At Assuta Hospital, patients can access Autologous Chondrocyte Implantation (ACI) through specialised cartilage restoration facilities staffed by experienced orthopaedic specialists. Established in 1934, the JCI hospital is located in Tel Aviv, Israel, and has 300 beds.

ACI uses the patient's own cartilage cells to help repair a localised cartilage defect. The treatment generally involves two stages: harvesting healthy chondrocytes and expanding them in a laboratory, followed by implantation into the damaged area. Imaging and clinical assessment help determine whether the patient is suitable for this treatment.

With advanced orthopaedic and cartilage-care infrastructure, Tel Aviv Sourasky Medical Center -Ichilov Hospital offers Autologous Chondrocyte Implantation (ACI) for eligible patients with specific cartilage injuries. Established in 1963, the JCI hospital is located in Tel Aviv, Israel, and has 1500 beds.

ACI may be considered for symptomatic, localised cartilage defects when other treatments have not provided adequate relief. The patient's own cartilage cells are harvested, multiplied in a laboratory, and later implanted into the affected area. A detailed evaluation of the cartilage lesion and surrounding joint structures is performed before treatment.